搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
15 小时
2400万患者的福音!精神分裂症新药在美获批,市场潜力如何?
本文来源:时代财经 作者:张羽岐 图片来源:图虫创意 全球首款新型抗精神分裂症药物在美国获批。9月26日,百时美施贵宝(BMS)的FIC(First-in-class,全球首创)Cobenfy (xanomeline和trospium ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
High-end brothel plea
Helene: How to help
'Harry Potter' star dies
ICE: Convicts roaming free
Troops to leave some bases
Diocese reaches settlement
Stadiums to serve as shelters
Promotes watch collection
Targeted Black residents?
World's oldest cheese found
Killer gets life sentence
KY sues Express Scripts
Fed inflation gauge cools
Meta hit with privacy fine
ISR targets Hezbollah HQ
Deposition in AI suit
US charges three Iranians
NIH finds misconduct
More executives leave
Ending password-sharing
On Secret Service failures
Pleads not guilty
50/50 ball ownership suit
Fake Biden robocalls fine
Urgent safety alert for 737s
Boxes to distribute Narcan
Producing doc on Diddy
WI duplicate ballot flap
NC board removes 747K
反馈